# Dendritic Cell Based Therapy of Renal Cell Carcinoma

> **NCT00197860** · PHASE1,PHASE2 · COMPLETED · sponsor: **Inge Marie Svane** · enrollment: 40 (actual)

## Conditions studied

- Advanced Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** tumor antigen loaded autologous dendritic cells

## Key facts

- **NCT ID:** NCT00197860
- **Lead sponsor:** Inge Marie Svane
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197860, "Dendritic Cell Based Therapy of Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00197860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*